Sherri Burda

1.5k total citations
36 papers, 1.2k citations indexed

About

Sherri Burda is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Sherri Burda has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Virology, 25 papers in Infectious Diseases and 7 papers in Epidemiology. Recurrent topics in Sherri Burda's work include HIV Research and Treatment (33 papers), HIV/AIDS drug development and treatment (20 papers) and HIV/AIDS Research and Interventions (13 papers). Sherri Burda is often cited by papers focused on HIV Research and Treatment (33 papers), HIV/AIDS drug development and treatment (20 papers) and HIV/AIDS Research and Interventions (13 papers). Sherri Burda collaborates with scholars based in United States, Cameroon and China. Sherri Burda's co-authors include Phillipe N. Nyambi, Susan Zolla‐Pazner, Constance Williams, Arthur Nádas, Miroslaw K. Górny, Mateusz M. Urbanski, Frank Konings, Barbara Volsky, Serena Xu and Henry A. Mbah and has published in prestigious journals such as PLoS ONE, Journal of Virology and The Journal of Infectious Diseases.

In The Last Decade

Sherri Burda

35 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sherri Burda United States 20 1.1k 603 443 254 219 36 1.2k
Leo Heyndríckx Belgium 24 1.1k 1.0× 938 1.6× 365 0.8× 278 1.1× 236 1.1× 63 1.5k
Blake Wood United States 8 1.3k 1.2× 521 0.9× 773 1.7× 242 1.0× 322 1.5× 11 1.4k
J J de Jong Netherlands 12 1.3k 1.2× 887 1.5× 402 0.9× 250 1.0× 232 1.1× 15 1.4k
Innocent Mboudjeka United States 18 749 0.7× 402 0.7× 371 0.8× 252 1.0× 269 1.2× 22 1.0k
Krisha Svehla United States 10 975 0.9× 329 0.5× 701 1.6× 226 0.9× 299 1.4× 10 1.1k
Constantinos Kurt Wibmer South Africa 12 923 0.9× 972 1.6× 593 1.3× 207 0.8× 460 2.1× 17 1.7k
Tandile Hermanus South Africa 10 679 0.6× 919 1.5× 450 1.0× 182 0.7× 389 1.8× 24 1.5k
Lilian Nogueira United States 12 941 0.9× 761 1.3× 686 1.5× 264 1.0× 231 1.1× 12 1.5k
Kelli Greene United States 11 1.5k 1.4× 672 1.1× 799 1.8× 330 1.3× 390 1.8× 17 1.7k
Melissa-Rose Abrahams South Africa 15 683 0.6× 402 0.7× 344 0.8× 186 0.7× 194 0.9× 30 897

Countries citing papers authored by Sherri Burda

Since Specialization
Citations

This map shows the geographic impact of Sherri Burda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherri Burda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherri Burda more than expected).

Fields of papers citing papers by Sherri Burda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherri Burda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherri Burda. The network helps show where Sherri Burda may publish in the future.

Co-authorship network of co-authors of Sherri Burda

This figure shows the co-authorship network connecting the top 25 collaborators of Sherri Burda. A scholar is included among the top collaborators of Sherri Burda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherri Burda. Sherri Burda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burda, Sherri, Kaitlyn Hess, Digamber Behera, et al.. (2014). Development of a POC Test for TB Based on Multiple Immunodominant Epitopes of M. tuberculosis Specific Cell-Wall Proteins. PLoS ONE. 9(9). e106279–e106279. 9 indexed citations
2.
Burda, Sherri, Constance Williams, Leo Heyndríckx, et al.. (2011). Longitudinal Study of Primary HIV-1 Isolates in Drug-Naïve Individuals Reveals the Emergence of Variants Sensitive to Anti-HIV-1 Monoclonal Antibodies. PLoS ONE. 6(2). e17253–e17253. 4 indexed citations
3.
Ragupathy, Viswanath, Jiangqin Zhao, Xue Wang, et al.. (2009). Comparative analysis of cell culture and prediction algorithms for phenotyping of genetically diverse HIV-1 strains from Cameroon. AIDS Research and Therapy. 6(1). 27–27. 4 indexed citations
4.
Nyambi, Phillipe N., Sherri Burda, Mateusz M. Urbanski, et al.. (2008). Neutralization Patterns and Evolution of Sequential HIV Type 1 Envelope Sequences in HIV Type 1 Subtype B-Infected Drug-Naive Individuals. AIDS Research and Human Retroviruses. 24(12). 1507–1519. 5 indexed citations
5.
Powell, Rebecca, Mateusz M. Urbanski, Sherri Burda, et al.. (2008). Utility of the Heteroduplex Assay (HDA) as a Simple and Cost-Effective Tool for the Identification of HIV Type 1 Dual Infections in Resource-Limited Settings. AIDS Research and Human Retroviruses. 24(1). 100–105. 6 indexed citations
6.
Zhao, Jiangqin, Frank Konings, Shixing Tang, et al.. (2007). Identification of a Novel Circulating Recombinant Form (CRF) 36_cpx in Cameroon That Combines Two CRFs (01_AE and 02_AG) with Ancestral Lineages of Subtypes A and G. AIDS Research and Human Retroviruses. 23(8). 1008–1019. 25 indexed citations
7.
Zhao, Jiangqin, Frank Konings, Shixing Tang, et al.. (2007). Circulating Recombinant Form (CRF) 37_cpx: An Old Strain in Cameroon Composed of Diverse, Genetically Distant Lineages of Subtypes A and G. AIDS Research and Human Retroviruses. 23(7). 923–933. 28 indexed citations
8.
Powell, Rebecca, Frank Konings, Aubin Nanfack, et al.. (2007). Quasispecies analysis of novel HIV‐1 recombinants of subtypes A and G reveals no similarity to the mosaic structure of CRF02_AG. Journal of Medical Virology. 79(9). 1270–1285. 5 indexed citations
9.
Konings, Frank, Yile Xue, Mateusz M. Urbanski, et al.. (2006). Genetic Analysis of HIV-1 Strains in Rural Eastern Cameroon Indicates the Evolution of Second-Generation Recombinants to Circulating Recombinant Forms. JAIDS Journal of Acquired Immune Deficiency Syndromes. 42(3). 331–341. 40 indexed citations
10.
Konings, Frank, Sherri Burda, Mateusz M. Urbanski, et al.. (2006). Human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02_AG (CRF02_AG) has a higher in vitro replicative capacity than its parental subtypes A and G. Journal of Medical Virology. 78(5). 523–534. 47 indexed citations
11.
Burda, Sherri, et al.. (2004). HIV-1 CRF09_cpx Circulates in the North West Province of Cameroon Where CRF02_AG Infections Predominate and Recombinant Strains Are Common. AIDS Research and Human Retroviruses. 20(12). 1358–1363. 25 indexed citations
12.
Nádas, Arthur, Ping Zhong, Sherri Burda, et al.. (2004). Defining Human Immunodeficiency Virus (HIV) Type 1 Immunotypes with Six Human Monoclonal Antibodies. AIDS Research and Human Retroviruses. 20(1). 55–65. 4 indexed citations
13.
Zhong, Ping, Sherri Burda, Frank Konings, et al.. (2003). Genetic and Biological Properties of HIV Type 1 Isolates Prevalent in Villagers of the Cameroon Equatorial Rain Forests and Grass Fields: Further Evidence of Broad HIV Type 1 Genetic Diversity. AIDS Research and Human Retroviruses. 19(12). 1167–1178. 39 indexed citations
14.
Nyambi, Phillipe N., Léopold Zekeng, Marcel Tongo, et al.. (2002). HIV Infection in Rural Villages of Cameroon. JAIDS Journal of Acquired Immune Deficiency Syndromes. 31(5). 506–513. 43 indexed citations
15.
Nyambi, Phillipe N., et al.. (2001). A virus binding assay for studying the antigenic landscape on intact, native, primary human immunodeficiency virus-type 1. Journal of Immunological Methods. 253(1-2). 253–262. 11 indexed citations
16.
Zolla‐Pazner, Susan, Serena Xu, Sherri Burda, et al.. (1998). Neutralization of Syncytium‐Inducing Primary Isolates by Sera from Human Immunodeficiency Virus (HIV)–Uninfected Recipients of Candidate HIV Vaccines. The Journal of Infectious Diseases. 178(5). 1502–1506. 13 indexed citations
17.
Górny, Miroslaw K., John R. Mascola, Zimra R. Israel, et al.. (1998). A Human Monoclonal Antibody Specific for the V3 Loop of HIV Type 1 Clade E Cross-Reacts with Other HIV Type 1 Clades. AIDS Research and Human Retroviruses. 14(3). 213–221. 19 indexed citations
18.
Hioe, Catarina E., et al.. (1997). Resting Cell Neutralization Assay for HIV-1 Primary Isolates. Methods. 12(4). 300–305. 2 indexed citations
19.
Zolla‐Pazner, Susan, Carl R. Alving, Robert B. Belshe, et al.. (1997). Neutralization of a Clade B Primary Isolate by Sera from Human Immunodeficiency Virus—Uninfected Recipients of Candidate AIDS Vaccines. The Journal of Infectious Diseases. 175(4). 764–774. 39 indexed citations
20.
Laal, Suman, Sherri Burda, Sandra Sharpe, & Susan Zolla‐Pazner. (1993). A Rapid, Automated Microtiter Assay for Measuring Neutralization of HIV-1. AIDS Research and Human Retroviruses. 9(8). 781–785. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026